CoatesA., GebskiM., CoatesA., GebskiV., BishopJ.F., JealP.N., WoodsR.L., SnyderR., TattersallM.H.N., ByrneM., HarveyV., GillG., SimpsonJ., DrummondR., BrowneJ., Van CootenR., ForbesJ.F.: Improving the quality of life during chemotherapy for advanced breast cancer. N. Engl. J. Med., 317: 1490–1495, 1987.
2.
CocconiG.: Follow-up of patients with breast cancer. (Letter). JAMA, 272: 1657–1658, 1994.
3.
CrippaF., BombardieriE., SeregniE., CastellaniM.R., GaspariniM., MaffioliL., PizzichettaM., BuraggiG.L.: Single determination of CA 15.3 and bone scintigraphy in the diagnosis of skeletal metastases of breast cancer. J. Nucl. Biol. Med., 36: 52–55, 1992.
4.
CrippaF., SeregniE., AgrestiR., BombardieriE., BuraggiG.L.: Bone scintigraphy in breast cancer: a ten-year follow-up study. J. Nucl. Biol. Med., 37: 57–61, 1993.
5.
HarrisJ.R., MorrowM., BonadonnaG.: Cancer of the breast. In: Cancer: principles and practice of oncology, De VitaV.T., HellmanS., RosenbergS.A., pp. 1264–1332, Lippincott JB Co., Philadelphia, 1993.
6.
KambyC.: The pattern of metastases in human breast cancer: methodological aspects and influence of prognostic factors. Cancer Treat. Rev., 17: 37–61, 1990.
7.
LoprinziC.L.: It is now the age to define the appropriate follow-up of primary breast cancer patients. J. Clin. Oncol., 12: 881–883, 1994.
8.
Rosselli Del TurcoM., PalliD., CariddiA., CiattoS., PaciniP., DistanteV.: Intensive diagnostic follow-up after treatment of primary breast cancer. JAMA, 271: 1593–1597, 1994.
9.
SchapiraD.V., UrbanN.: A minimalist policy for breast cancer surveillance. JAMA, 265: 380–382, 1991.
10.
The GIVIO Investigators.Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. JAMA, 271: 1587–1592, 1994.
11.
ValagussaP., BonadonnaG., VeronesiU.: Patterns of relapse and survival following radical mastectomy. Cancer, 41: 1170–1178, 1978.
12.
WertheimerM.D.: Against minimalism in breast cancer follow-up. JAMA, 265: 396–397, 1991.
13.
WikenheiserK.A., SilbersteinE.B.: Bone scintigraphy screening in stage I-II breast cancer: is it cost effective? Cleve Clin. J. Med., 63: 43–47, 1996.